Government Affairs
The Government Affairs division is the Chamber’s lobbying team headquartered in Washington with regional offices across the country. We champion the Chamber’s pro-business priorities and advocate for America’s free enterprise system on Capitol Hill.
Chamber Strength
The Chamber is an effective advocacy organization thanks to its broad membership base, extensive federation network, active grassroots engagement, robust policy experience, strong lobbying expertise, proactive free enterprise agenda, and long-standing pro-business reputation.
Our Influence
The Government Affairs DC and Regional Teams play a vital role in the Chamber’s advocacy efforts and effectiveness through legislative lobbying, subject matter expertise, strategic relationship engagement, coalition participation, and policy monitoring, analysis, and reporting.
Hill Leadership
The Hill Team brings expertise and strategic acumen to shape strategy, build alliances, and drive effective advocacy on both sides of the aisle through direct Capitol Hill engagement.
Beyond the Beltway
The Regional Team cultivates relationships among local, regional, and state chambers, association partners, and businesses large and small to show support for pro-growth legislation in the communities that Members of Congress represent.
Relationship Building
Central to the work of the Government Affairs Team is building stronger relationships with members of Congress that foster trust, support decision-making, enhance credibility and expertise, and promote collaboration to enable effective long-term legislative and political success.
Recent Work
The Growth and Opportunity Imperative for America
The U.S. Chamber believes America needs a national priority for growth, driven by people through innovation and productivity and fostered through sound public policy. That's why we are outlining policies that will help us reach the goal of 3% annual real economic growth.
Learn More
Leadership
Go in Depth
See the Policymakers and Leaders Who Meet with the Chamber
Policymakers, business leaders, and top officials meet with the Chamber every year to discuss issues and champion pro-business priorities.
Learn More
Latest Content
This Hill letter was sent to the Members of the United States Congress, supporting S. 1117 / H.R. 2406, the “Accelerate Long-term Investment Growth Now (ALIGN) Act.”
This Hill letter was sent to the Members of the United States Congress, supporting S. 1232 / H.R. 2788, the “American Investment in Manufacturing (AIM) Act.”
This Hill letter was sent to the Members of the House Committee on Natural Resources, supporting H.Con.Res. 34, "expressing disapproval of the withdrawal by the Secretary of the Interior of approximately 225,504 acres of National Forest System lands in Cook, Lake, and Saint Louis Counties, Minnesota, from disposition under the United States mineral and geothermal leasing laws," as well as H.R. 3195, the “Superior National Forest Restoration Act."
This letter was sent to the Members of the United States Congress, supporting S. 866, the “American Innovation and Jobs Act,” and H.R. 2673, the “American Innovation and R&D Competitiveness Act.”
This Statement for the Record was sent to the Senate Judiciary committee, submitting the AI Commission's report for the hearing, "Oversight of A.I: Rules for Artificial Intelligence."
This Hill letter was sent to the Members of the U.S. House of Representatives, supporting H.R. 1163, the "Protecting Taxpayers and Victims of Unemployment Fraud Act."
This Statement for the Record was sent to the Members of the House Committee on Oversight & Accountability, for the hearing, "Costly Inaction on Federal Legacy IT."
This Hill letter was sent to the Members of the House Committee on the Judiciary, opposing H.R. 3081, the “No Oil Producing and Exporting Cartels Act."
This Statement for the Record was sent to the Members of the Senate Committee on the Judiciary, on the hearing "Competition in the Digital Advertising Ecosystem."
This Hill letter was sent to the Members of the Senate Committee on Health, Education, Labor and Pensions, on S. 1067, the "Ensuring Timely Access to Generics Act of 2023,” S. 1114, the “Expanding Access to Low-Cost Generics Act of 2023,” S. 1214, the “RARE Act,” and S. 1339, the “Pharmacy Benefit Manager Reform Act.”